238 related articles for article (PubMed ID: 35293586)
1. Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy.
Espinosa KG; Geissah S; Groom L; Volpatti J; Scott IC; Dirksen RT; Zhao M; Dowling JJ
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35293586
[TBL] [Abstract][Full Text] [Related]
2. Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model.
Li Q; Lin J; Widrick JJ; Luo S; Li G; Zhang Y; Laporte J; Perrella MA; Liu X; Agrawal PB
JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35763354
[TBL] [Abstract][Full Text] [Related]
3. Striated Preferentially Expressed Protein Kinase (SPEG)-Deficient Skeletal Muscles Display Fewer Satellite Cells with Reduced Proliferation and Delayed Differentiation.
Li Q; Lin J; Rosen SM; Zhang T; Kazerounian S; Luo S; Agrawal PB
Am J Pathol; 2020 Dec; 190(12):2453-2463. PubMed ID: 32919980
[TBL] [Abstract][Full Text] [Related]
4. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
5. SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy.
Agrawal PB; Pierson CR; Joshi M; Liu X; Ravenscroft G; Moghadaszadeh B; Talabere T; Viola M; Swanson LC; Haliloğlu G; Talim B; Yau KS; Allcock RJ; Laing NG; Perrella MA; Beggs AH
Am J Hum Genet; 2014 Aug; 95(2):218-26. PubMed ID: 25087613
[TBL] [Abstract][Full Text] [Related]
6. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
7. SPEG-deficient skeletal muscles exhibit abnormal triad and defective calcium handling.
Huntoon V; Widrick JJ; Sanchez C; Rosen SM; Kutchukian C; Cao S; Pierson CR; Liu X; Perrella MA; Beggs AH; Jacquemond V; Agrawal PB
Hum Mol Genet; 2018 May; 27(9):1608-1617. PubMed ID: 29474540
[TBL] [Abstract][Full Text] [Related]
8. Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei.
Lornage X; Sabouraud P; Lannes B; Gaillard D; Schneider R; Deleuze JF; Boland A; Thompson J; Böhm J; Biancalana V; Laporte J
J Neuromuscul Dis; 2018; 5(2):257-260. PubMed ID: 29614691
[TBL] [Abstract][Full Text] [Related]
9. Insights from genotype-phenotype correlations by novel SPEG mutations causing centronuclear myopathy.
Wang H; Castiglioni C; Kaçar Bayram A; Fattori F; Pekuz S; Araneda D; Per H; Erazo R; Gümüş H; Zorludemir S; Becker K; Ortega X; Bevilacqua JA; Bertini E; Cirak S
Neuromuscul Disord; 2017 Sep; 27(9):836-842. PubMed ID: 28624463
[TBL] [Abstract][Full Text] [Related]
10. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.
Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z
Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679
[TBL] [Abstract][Full Text] [Related]
11. SPEG binds with desmin and its deficiency causes defects in triad and focal adhesion proteins.
Luo S; Li Q; Lin J; Murphy Q; Marty I; Zhang Y; Kazerounian S; Agrawal PB
Hum Mol Genet; 2021 Feb; 29(24):3882-3891. PubMed ID: 33355670
[TBL] [Abstract][Full Text] [Related]
12. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
Liewluck T; Lovell TL; Bite AV; Engel AG
Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
[TBL] [Abstract][Full Text] [Related]
13. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
[TBL] [Abstract][Full Text] [Related]
14. Novel SPEG mutations in congenital myopathies: Genotype-phenotype correlations.
Qualls AE; Donkervoort S; Herkert JC; D'gama AM; Bharucha-Goebel D; Collins J; Chao KR; Foley AR; Schoots MH; Jongbloed JDH; Bönnemann CG; Agrawal PB
Muscle Nerve; 2019 Mar; 59(3):357-362. PubMed ID: 30412272
[TBL] [Abstract][Full Text] [Related]
15. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
[TBL] [Abstract][Full Text] [Related]
16. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
[TBL] [Abstract][Full Text] [Related]
17. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
[TBL] [Abstract][Full Text] [Related]
19. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
20. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
